ENBIO Extraordinary General Meeting Passes Articles Amendment and Capital Reserve Transfer for Operational Efficiency - Limited Impact on Shareholder Value


  • ENBIO held its extraordinary general meeting on June 17, 2026, and approved all three agenda items: amendment of articles of incorporation, appointment of auditor, and transfer of capital reserves to retained earnings.
  • The articles amendment includes deletion of non-operating businesses such as diagnostic kits, special valves, and renewable energy, as well as relocation of the head office from Gunpo to Suwon.
  • Auditor Ham Soo-yong, a certified public accountant and tax accountant, was reappointed with a majority vote via electronic voting.
  • To cover accumulated deficits, 20 billion KRW out of 46.098 billion KRW in capital reserves will be transferred to retained earnings, improving the balance sheet structure.
  • Since the transfer only reclassifies internal equity items with no change in total capital, there is no direct dilution effect on share value.
  • The company aims to streamline its business portfolio and enhance operational efficiency through these changes.
  • [AI Summary]The agenda items are all routine measures for operational efficiency and legal compliance, with limited direct impact on shareholder value. The capital reserve transfer improves financial structure but is neutral as total equity remains unchanged. The deletion of businesses reflects underperformance relative to past investments.

KOSDAQ Filing Information


  • Result of Extraordinary General Meeting of Shareholders
  • Company: ENBIOCO (352940)
  • Submission: ENBIOCO., LTD.
  • Under KRX KOSDAQ Market Division

  • Shares: 10,867,730
  • Price: 2,075 KRW
  • Market Cap: 22.6 B KRW